| Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges I Kufareva, V Katritch, RC Stevens, R Abagyan Structure 22 (8), 1120-1139, 2014 | 181 | 2014 |
| Computational polypharmacology: a new paradigm for drug discovery R Chaudhari, Z Tan, B Huang, S Zhang Expert opinion on drug discovery 12 (3), 279-291, 2017 | 101 | 2017 |
| An up-to-date overview of computational polypharmacology in modern drug discovery R Chaudhari, LW Fong, Z Tan, B Huang, S Zhang Expert opinion on drug discovery 15 (9), 1025-1044, 2020 | 52 | 2020 |
| Polypharmacology in drug development: a minireview of current technologies Z Tan, R Chaudhai, S Zhang ChemMedChem 11 (12), 1211-1218, 2016 | 41 | 2016 |
| PyMine: a PyMOL plugin to integrate and visualize data for drug discovery R Chaudhari, Z Li BMC Research Notes 8, 1-5, 2015 | 40 | 2015 |
| Conversion of RNA aptamer into modified DNA aptamers provides for prolonged stability and enhanced antitumor activity P Amero, GLR Lokesh, RR Chaudhari, R Cardenas-Zuniga, T Schubert, ... Journal of the American Chemical Society 143 (20), 7655-7670, 2021 | 37 | 2021 |
| Directed evolution of cyclic peptides for inhibition of autophagy JP Gray, MN Uddin, R Chaudhari, MN Sutton, H Yang, P Rask, H Locke, ... Chemical Science 12 (10), 3526-3543, 2021 | 29 | 2021 |
| Caspase-3 substrates for noninvasive pharmacodynamic imaging of apoptosis by PET/CT BJ Engel, ST Gammon, R Chaudhari, Z Lu, F Pisaneschi, H Yang, ... Bioconjugate chemistry 29 (9), 3180-3195, 2018 | 20 | 2018 |
| Creating novel translation inhibitors to target pro-survival proteins in chronic lymphocytic leukemia R Chen, M Zhu, RR Chaudhari, O Robles, Y Chen, W Skillern, Q Qin, ... Leukemia 33 (7), 1663-1674, 2019 | 19 | 2019 |
| Structural modeling and in silico screening of potential small-molecule allosteric agonists of a glucagon-like peptide 1 receptor T Redij, R Chaudhari, Z Li, X Hua, Z Li ACS omega 4 (1), 961-970, 2019 | 19 | 2019 |
| Improving homology modeling of G-protein coupled receptors through multiple-template derived conserved inter-residue interactions R Chaudhari, AJ Heim, Z Li Journal of computer-aided molecular design 29, 413-420, 2015 | 12 | 2015 |
| Targeting forward and reverse EphB4/EFNB2 signaling by a peptide with dual functions C Xiong, Y Wen, J Zhao, D Yin, L Xu, A Chelariu-Raicu, C Yao, X Leng, ... Scientific reports 10 (1), 520, 2020 | 10 | 2020 |
| Overview of drug polypharmacology and multitargeted molecular design R Chaudhari, Z Tan, S Zhang Drug Discovery Technologies, 258-275, 2017 | 8 | 2017 |
| JavaDL: a Java-based Deep Learning Tool to Predict Drug Responses B Huang, LWR Fong, R Chaudhari, Z Tan, S Zhang bioRxiv, 2020.05. 04.077701, 2020 | | 2020 |
| Putting the Brakes on Translation–A Computational Study to Understand the Mechanism of Translation Inhibition by Pateamine A and Analogs RR Chaudhari Thursday, September 12| Onstead Auditorium, 51, 2019 | | 2019 |
| STRUCTURAL MODELING AND IN SILICO SCREENING OF POTENTIAL SMALL MOLECULE ALLOSTERIC AGONISTS OF GLP-1 RECEPTOR Z Li, T Redij, R Chaudhari, Z Li, X Hua PROTEIN SCIENCE 28, 98-98, 2019 | | 2019 |
| Novel pateamine analogs to target the translation initiation factor eIF4A in chronic lymphocytic leukemia R Chen, M Zhu, RR Chaudhari, O Robles, Y Chen, W Skillern, Q Qin, ... Cancer Research 79 (13_Supplement), 1854-1854, 2019 | | 2019 |
| Next generation DNA aptamers with prolonged stability and antitumor activity P Amero, C Rodriguez-Aguayo, RR Chaudhari, S Zhang, AK Sood, ... Cancer Research 79 (13_Supplement), 368-368, 2019 | | 2019 |
| Development of novel modified aptamers to target Axl receptor in ovarian cancer P Amero, C Rodriguez-Aguayo, GLR Lokesh, E Bayraktar, C Ivan, ... Annals of Oncology 29, iii17, 2018 | | 2018 |
| Rational Design of AGO-Allosteric Small Molecule of GLP-1R T Redij, R Chaudhari, Z Li, Z Li Biophysical Journal 114 (3), 55a, 2018 | | 2018 |
Shuxing ZhangMD Anderson Cancer CenterVerified email at mdanderson.org
